 |
|
Should compulsory screening of immigrants be part of UK public health policy?
February 05, 2004The UK government may be considering compulsory screening of immigrants for tuberculosis and HIV, yet compulsory screening is not based on adequate evidence and has practical and ethical problems, argues a senior doctor in this week's BMJ.
Little evidence exists to show that early detection of tuberculosis in foreign born individuals conveys appreciable public health benefit to those born in the host country, writes Richard Coker of the London School of Hygiene and Tropical Medicine.
Indeed, what little evidence exists suggests that the introduction of compulsory measures may mean that some patients may delay seeking care and pose a greater public health threat.
HIV raises several important practical and ethical questions, he adds. For instance, would such a policy focus on all migrants, immigrants from high prevalence countries, asylum seekers, or some as yet unspecified population? And what about people from within the European Union who are able to move freely?
Furthermore, if a positive HIV status excludes an individual from entry (as has been proposed) then might such a screening policy create incentives to avoid legal routes of entry?
The United Kingdom has an enviable reputation in international public health, says the author. It would be a shame if this reputation was tarnished through an ill considered conflation of immigration control and communicable disease control.
British Medical Journal (BMJ)
HIV raises several important practical and ethical questions, he adds. For instance, would such a policy focus on all migrants, immigrants from high prevalence countries, asylum seekers, or some as yet unspecified population? And what about people from within the European Union who are able to move freely?
Furthermore, if a positive HIV status excludes an individual from entry (as has been proposed) then might such a screening policy create incentives to avoid legal routes of entry?
The United Kingdom has an enviable reputation in international public health, says the author. It would be a shame if this reputation was tarnished through an ill considered conflation of immigration control and communicable disease control.
British Medical Journal (BMJ)
Tuberculosis Current Events and Tuberculosis News RSSResearchers identify new leprosy bacterium
A new species of bacterium that causes leprosy has been identified through intensive genetic analysis of a pair of lethal infections, a research team reports in the December issue of the American Journal of Clinical Pathology.
Stopping germs from ganging up on humans
Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson.
First trachea transplant without immunosuppression
After 4 years of going from consultation to consultation, Claudia Castillo finally found a solution to her respiratory problems. The young Colombian woman suffered from a cough that took a long time to be diagnosed as tuberculosis.
Proteomics Study Yields Clues As To How Tuberculosis Might Be Thwarting The Immune System
A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases.
XDR-TB: Deadlier and more mysterious than ever
New research has found that XDR-TB is increasingly common and more deadly than previously known. Extensively drug-resistant tuberculosis (XDR-TB) is a growing public health threat that is only just beginning to be understood by medical and public health officials.
Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment
New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection.
Parasites that live inside cells use loophole to thwart immune system
St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide.
Persistent bacterial infection exploits killing machinery of immune cells
A new study reveals an important and newly discovered pathway used by disease-causing bacteria to evade the host immune system and survive and grow within the very cells meant to destroy them. This discovery may lead to new treatments and vaccines for tuberculosis (TB) and certain other chronic bacterial and parasitic infections.
Health Care Barriers for Undocumented Immigrants: Raising Tuberculosis Risk?
A new study raises the question, do barriers to health care for undocumented immigrants increase the public health risk of tuberculosis? The study, published in the November 15, 2008 issue of Clinical Infectious Diseases and now available online, suggests that undocumented immigrants with tuberculosis have symptoms longer before seeking care than documented immigrants or U.S.-born patients, resulting in more severe symptoms and more opportunities for transmission.
UCLA develops safer, more effective TB vaccine for HIV-positive people
UCLA scientists engineered a new tuberculosis (TB) vaccine specifically designed for HIV-positive people that was shown to be safer and more potent than the current TB vaccine in preclinical trials.
More Tuberculosis Current Events and Tuberculosis News Articles
 | The Bioarchaeology of Tuberculosis: A Global View on a Reemerging Disease by CHARLOTTE ROBERTS, JANE BUIKSTRA Though apparently in decline during the first half of the 20th century, tuberculosis has reawakened in both developed and developing countries, particularly among susceptible populations with immunodeficiency disorders.... |
 | The Forgotten Plague: How the Battle Against Tuberculosis Was Won - And Lost by Frank Ryan Tuberculosis has claimed more than a billion lives worldwide. In this acclaimed book, Dr. Frank Ryan tells the remarkable story of the dedicated doctors, chemists, and bacteriologists who halted the course of this ferocious disease--until the "old enemy" found in AIDS a deadly ally to form a drug-resistant synergy. 8 pages of... |
| Clinician's Guide to Tuberculosis (Clinician's Guide to Tuberculosis (Iseman)) by Michael D. Iseman Univ. of Colorado, Denver. Clinical synopsis providing essential information for those unfamiliar with the disease. Addresses the problem of managing HIV-positive patients and drug-resistant strains. Discusses, basic science, epidemiology, transmission, vaccination, and prevention. Includes tables, references, and illustrations. Softcover. DNLM:... | |
 | Captain of Death: The Story of Tuberculosis by Thomas M. Daniel The dramatic story of tuberculosis is told here in a straightforward and accessible style. It presents the stories of persons connected with the disease, either as victims, or as those who made contributions to our knowledge of it; in addition to these personal accounts, the book unfolds the history and explains the pathogenesis of TB. The re-emergence of tuberculosis as a major American public... |
 | The White Plague: Tuberculosis, Man, and Society by Rene J. Dubos |
 | Tuberculosis (TUBERCULOSIS ( ROM)) New York Univ., NY. Summarizes the current advances in tuberculosis and discusses the pathology and pathogenesis of the disease. Also covers complications and treatment options. Chapters include history and epidemiology, genomics and microbiology, host response, therapy, and prevention and control. Previous edition: c1996. DNLM:... |
| Diagnostic Standards and Classification of Tuberculosis - by National Tuberculosis and Respiratory Disease Association - | |
 | Tuberculosis and Nontuberculosis Mycobacterial Infections by David Schlossberg The Definitive Text on Tuberculosis Infections for More Than Two Decades!. . This trusted resource provides infectious disease specialists with the most comprehensive coverage found anywhere of the varied manifestations of tuberculin diseases and the clinical options available to physicians for treating them. The new edition has been updated to reflect state-of-the-art changes in the direction... |
| Tuberculosis (Deadly Diseases and Epidemics) by Kim Renee Finer, I. Edward Alcamo Experts in the field of microbiology tell the great "detective stories" of how some of the world's best-known deadly disease-causing microbes were first isolated, identified, and studied. Readers learn how these deadly viruses and bacteria cause disease and what steps have been taken to eradicate them. Tuberculosis killed one out of every seven people living in the United States and Europe in the... | |
 | Bargaining for Life: A Social History of Tuberculosis, 1876-1938 (Studies in Health, Illness, and Caregiving in America) by Barbara Bates Using a wide range of sources, especially the extensive correspondence of a Philadelphia physician, Lawrence F. Flick, Barbara Bates portrays the lives of tuberculous men and women as they tried to cope with the illness, get treatment, earn their living, and maintain their social... |
| © 2008 BrightSurf.com |